Robert W. Baird initates Intra-Cellular Therapies Inc (ITCI) rating to an Outperform
In a filing, Intra-Cellular Therapies Inc revealed its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $69.19 million. Then, Hineline Lawrence […]
Chairman, President & CEO Mates Sharon sold 20,565 shares of Intra-Cellular Therapies Inc [ITCI]
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies Inc shares valued at $1,341,123 were sold by Mates Sharon on Mar 11 ’24. At $65.21 per share, Mates Sharon sold 20,565 shares. The insider’s holdings dropped to 1,050,309 shares worth approximately $70.66 million following […]
Analysts review Intra-Cellular Therapies Inc’s rating
Intra-Cellular Therapies Inc’s filing revealed that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $71.88 million. Then, Hineline Lawrence J. […]
Sharp decrease in ITCI’s short interest leads to decline in days-to-cover ratio
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Intra-Cellular Therapies Inc shares valued at $1,341,123 were sold by Mates Sharon on Mar 11 ’24. At $65.21 per share, Mates Sharon sold 20,565 shares. The insider’s holdings dropped to 1,050,309 […]
Checking in on Intra-Cellular Therapies Inc (ITCI) after recent insiders movement
Intra-Cellular Therapies Inc’s recent filing unveils that its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $72.68 million. Then, Hineline Lawrence […]
Intra-Cellular Therapies Inc (ITCI) receives an Outperform rating from Robert W. Baird
In a filing, Intra-Cellular Therapies Inc revealed its Chairman, President & CEO Mates Sharon unloaded Company’s shares for reported $1.34 million on Mar 11 ’24. In the deal valued at $65.21 per share,20,565 shares were sold. As a result of this transaction, Mates Sharon now holds 1,050,309 shares worth roughly $72.49 million. Then, Hineline Lawrence […]
Intra-Cellular Therapies (ITCI) Announces $350M Public Offering of Common Stock
Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment for certain bipolar disorders, ITCI stock surged 73% on Wednesday. Intra-Cellular Therapies, Inc. (ITCI) stock made a massive move on Wednesday surging up to 73% at close. The stock price sky-rocketed initially from the update […]